A Conversation About Pharmaceutical Supply Chain Resilience and COVID-19
On October 27, HDA and The Hill brought together policymakers, leaders in the pharmaceutical industry and public health experts to discuss the supply chain’s response during COVID-19. Read More
tagged with: Covid-19EfficiencyPharmacyReliabilitySafety